EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Boron‐Based Functionalities Enhance the Potency of 2,5‐Dimethylfuran‐Based IDO1 Inhibitors

Thomas J C Carraro, Samrat Dasgupta, Jacqueline Ku, Shane R Thomas, Louis M Rendina iD

ChemBioChem · 2025

DOI: 10.1002/cbic.202500134 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemBioChem, 2025. Verfasst von Thomas J C Carraro und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry, The University of Sydney, Sydney, NSW, 2006, Australia. Hauptthemen laut MEDLINE: Indoleamine-Pyrrole 2,3,-Dioxygenase, Enzyme Inhibitors, Furans, Boron. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Indoleamine‐2,3‐dioxygenase‐1 (IDO1) is a critical immunoregulatory enzyme responsible for the metabolism of tryptophan during inflammation and disease. Based on a 2,5‐dimethylfuran framework, examples of indoleamine‐2,3‐dioxygenase 1 (IDO1) inhibitors containing a diverse set of boron‐based functional groups ( closo ‐1,2‐ and 1,7‐carborane, boronic acids and esters, and benzoxaboroles) are reported. The novel boron derivatives display low micrometer affinity for the human recombinant enzyme, with IC50 values ranging from 8 to 60 μM. Superior results are observed for the closo ‐carborane compounds which demonstrate a significant improvement in potency over their phenyl analogues, with inhibition of the IDO1 enzyme increased by up to ≈80%.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Indoleamine-Pyrrole 2,3,-DioxygenaseEnzyme InhibitorsFuransBoronBoron CompoundsHumansStructure-Activity RelationshipMolecular Structure

Stichwörter der Autor:innen

boroncarboranesdrug discoveriesindoleamine‐2,3‐dioxygenase‐1inhibitors

Substanzen

Indoleamine-Pyrrole 2,3,-DioxygenaseEnzyme InhibitorsFuransIDO1 protein, humanBoronBoron Compounds

Autor:innen und Institutionen

  • School of Chemistry, The University of Sydney, Sydney, NSW, 2006, Australia.
  • School of Biomedical Sciences, Faculty of Medicine & Health, The University of New South Wales, Sydney, 2052, Australia.
  • The University of Sydney Nano Institute (Sydney Nano), The University of Sydney, Sydney, NSW, 2006, Australia.

ORCID-Profile: Louis M Rendina

Zitieren

APA

Carraro, T. J. C., Dasgupta, S., Ku, J., Thomas, S. R., & Rendina, L. M. (2025). Boron‐Based Functionalities Enhance the Potency of 2,5‐Dimethylfuran‐Based IDO1 Inhibitors. ChemBioChem. https://doi.org/10.1002/cbic.202500134

Vancouver

Carraro TJC, Dasgupta S, Ku J, Thomas SR, Rendina LM. Boron‐Based Functionalities Enhance the Potency of 2,5‐Dimethylfuran‐Based IDO1 Inhibitors. ChemBioChem. 2025. doi:10.1002/cbic.202500134

BibTeX
@article{Carraro2025,
  author = {Carraro, Thomas J C and Dasgupta, Samrat and Ku, Jacqueline and Thomas, Shane R and Rendina, Louis M},
  title = {Boron‐Based Functionalities Enhance the Potency of 2,5‐Dimethylfuran‐Based IDO1 Inhibitors},
  journal = {ChemBioChem},
  year = {2025},
  doi = {10.1002/cbic.202500134}
}
Kostenlos starten →